Alkem Laboratories Acquires 51-55% Stake in Occlutech Holding AG to Enter Global Cardiovascular Market
Alkem MedTech is strategically acquiring a 51–55% stake in Occlutech Holding AG, a global player in minimally invasive cardiac devices, for a…